Method of Determining Risk of Autism Spectrum Disorder
AssigneeThe Hospital for Sick Children
InventorStephen Scherer
Life of this patent
Estimating the term…
Abstract
A method of assessing risk in a human subject of ASD is provided comprising the step of identifying in a nucleic acid-containing sample obtained from the human subject copy number variations associated with SHANK1. Determination of copy number variations associated with SHANK1 is indicative of a risk of ASD in the human subject.
Claims3
A method of assessing risk in a human subject of ASD comprising the step of identifying in a nucleic acid-containing sample obtained from the human subject copy number variations associated with SHANK1, wherein a determination of copy number variations associated with SHANK1 is indicative of a risk of ASD in the human subject.
A method of assessing risk in a human subject of ASD comprising the step of identifying in a protein acid-containing sample obtained from the human subject the expression or activity of a SHANK1 protein product, comparing the expression or activity of said protein product with the normal expression or activity of said product, wherein a determination of an expression or activity of said product that is different from said normal expression or activity is indicative of a risk of ASD in the human subject.
Dependencies are inferred from the claim text.